Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
- Marjorie Pick
- , Vladimir Vainstein
- , Neta Goldschmidt
- , David Lavie
- , Diana Libster
- , Alexander Gural
- , Sigal Grisariu
- , Batia Avni
- , Dina Ben Yehuda
- , Moshe E. Gatt*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
77
Scopus
citations